Nectar Lifesciences Limited
Share Price Target & Analysis
NSE:NECLIFE
VWAP
Open
Close
High
Low
52 Week High
-0.05 (-0.42%)
NECLIFE
(PHARMA)Turnaround Potential
52 Week Low
EPS
PE
PB
Uncertain
Quality
Unclear
Valuation
#Analysis
NSE: NECLIFE Share Price Financial Analysis & Valuation
Nectar Lifesciences Limited (NECLIFE) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical.
It is one of SME Stocks company with Market Capitalization of Rs 734.5 (in Cr). Total number of free float shares are 22.4 (in Lacs).
Nectar Lifesciences Limited is listed on NSE with Exchange ID - INE023H01027 and trading code is NSE:NECLIFE with short name Nectar Life.
In the past 1 year, Nectar Lifesciences Limited has declared an equity dividend of Rs 0 per share. At the current share price of NECLIFE at Rs 11.93, this results in a dividend yield of 0 %.
As per the Fundamental Analysis of NSE:NECLIFE, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine NECLIFE underlying value and future prospects. All of this data is available in NECLIFE financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:NECLIFE, it is clearly understood that NECLIFE is Uncertain performer in terms of earnings and profit margins with an EPS of -13.38. NSE:NECLIFE book value per share as of today is 25.51. The current price to book ratio for NECLIFE as of Sep 10, 2026 is 0.47.
Valuation of the Stock: The current valuation of NECLIFE stock is like Unclear which means currently the stock is Confusing. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of NECLIFE whether to BUY this stock at current valuation. The delivery percentage of NECLIFE is 90079% is very crucial parameter which shows that 90079% investors are anticipating that the price of NECLIFE share should go up with VWAP at 12.05.
Now, the main question is whether to BUY or SELL, NSE:NECLIFE at current valuation.
As per latest Analysis No. #3176:-
⇑ STRONG BUY NECLIFE if All Greens
⇗ BUY NECLIFE (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD NECLIFE (With Stop Loss) if only 1 Green
⇘ SELL NECLIFE if NO Green Indicator
NSE: NECLIFE Share Price Today (Sep 10, 2026)
(Nectar Lifesciences Limited Daily Analysis on the basis of NECLIFE Intraday Graph & Trend)
Nectar Lifesciences Limited share price moved Down by -0.42% from its previous close of Rs 11.98. NECLIFE stock last traded price is 11.93. NECLIFE share price trend is Down with a total of 87468 stocks traded till now. It has touched an intraday high of Rs 12.2 and an intraday low of Rs 11.9. The NECLIFE trading at 11.93, Down by Rs. -0.05, or -0.42 percent which suggests that most of the Traders are anticipating that the price of NECLIFE share should go Down.
NSE: NECLIFE Share Price Tomorrow Prediction
(Nectar Lifesciences Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of NECLIFE)
Nectar Lifesciences Limited share price moved Down by -0.42%. NECLIFE share price short term trend is Down. It suggests that NECLIFE Share Price for Tomorrow remains the same with VWAP at 12.05 will be treated as stop loss for intraday traders. Nectar Lifesciences Limited Long term investors can follow the NECLIFE long term trend as mentiond in future forecast table.
NSE Code |
NSE: NECLIFE |
NECLIFE Share Price Today |
11.93 |
NECLIFE Share Price Target Prediction for 2026 ^ |
9.8 - 16.9 |
NECLIFE Share Price Target Prediction for 2027*^ |
16.9 - 17.6 |
NECLIFE Share Price Target Prediction for 2028*^ |
17.6 - 18.5 |
NECLIFE Share Price Target Prediction for 2029*^ |
19 |
NECLIFE Share Price Target Prediction for 2030*^ |
20 |
NECLIFE Share Price Target Prediction for 2035*^ |
21 |
| NECLIFE Current Book Value |
25.4 |
*Nectar Lifesciences Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^NECLIFE share price target prediction for 2026 2027 2028 2029 2030 to 2035 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
NECLIFE Technical Analysis
Candlestick Pattern: @11.98| MA | Simple | Action S1 | Expo | Action E2 |
|---|---|---|---|---|
| MA_5 | 12.11 | SELL | 12.1 | SELL |
| MA_12 | 12.12 | SELL | 11.95 | BUY |
| MA_20 | 11.66 | BUY | 11.76 | BUY |
| MA_32 | 11.17 | BUY | 11.53 | BUY |
| MA_50 | 11.14 | BUY | 11.47 | BUY |
| MA_100 | 11.58 | BUY | 11.66 | BUY |
| MA_200 | 13.26 | SELL | 13.48 | SELL |
| Trend Oscillators | Value | Action |
|---|---|---|
| Bollinger Bands | 11.66 | Uptrend |
| MACD | 0.01 | BUY |
| ADX | 17.49 | NO or Weak Trend |
| DMI (+/-) | 21.63 / 21.79 | Downtrend |
| Momentum Oscillators | Value | Action |
|---|---|---|
| RSI | 55.47 | Neutral |
| STOCHASTIC_K (Fast) | 19.81 | Oversold |
| STOCHASTIC_D (Slow) | 34.28 | Neutral |
| CCI | 9.06 | Neutral |
| PSAR | 11.14 | BUY |
| TRUE RANGE | 0.46 | Neutral |
| ATR | 0.58 | Neutral |
| WILLIAMS R | -44.06 | Neutral |
| TRIX | 0 | Neutral |
| STOCHASTIC RSI K | 0 | Oversold |
| STOCHASTIC RSI D | 8.6 | Oversold |
| MOMENTUM | 1.48 | BUY |
| Duration | Value |
|---|---|
| 1 Year | -18.28% |
| 3 Months | 1.27% |
| 1 Month | 14.1% |
| 1 Week | -2.68% |
| Action | Overall (%) |
|---|---|
| BUY | 43% |
| NEUTRAL / HOLD | 27% |
| SELL | 30% |
Most popular Questions & Answers about NECLIFE (/ FAQ NECLIFE)
Nectar Lifesciences Limited stock last traded price is 11.93. NECLIFE share price moved Down by -0.42% from its previous close of Rs 11.98.
Nectar Lifesciences Limited share price trend is Down with a total of 87468 stocks traded till now. It has touched an intraday high of Rs 22.624 and an intraday low of Rs 11.9. The NECLIFE trading at 11.93, Down by Rs. -0.05, or -0.42 percent which suggests that most of the Traders are anticipating that the price of NECLIFE share should go Down and the Stop Loss will be around 12.05.
The market cap of Nectar Lifesciences Limited is ₹734.5 (in Cr) as of Sep 09, 2026.
The current price to earning ratio for Nectar Lifesciences Limited as of Sep 09, 2026 is -1.1.
The current price to book ratio for Nectar Lifesciences Limited as of Sep 09, 2026 is 0.47.
The highest price of Nectar Lifesciences Limited stock is ₹22.4 in the last 52-week.
The lowest price of Nectar Lifesciences Limited stock is ₹9.3 in the last 52-week.
Nectar Lifesciences Limited share trading at ₹11.93, Down by Rs. -0.05, or -0.42 percent which suggests that most of the traders are anticipating that the price of NECLIFE share should go Down.
In 2026, Stock price target for Nectar Lifesciences Limited (NECLIFE) will be around ₹9.8 on downside and ₹16.9 on upside. Nectar Lifesciences Limited share price target is based on current financial year earings of the company.
In 2027, Stock price target for Nectar Lifesciences Limited (NECLIFE) will be around ₹16.9 on downside and ₹17.6 on upside. Nectar Lifesciences Limited share price target is based on forecasted future earnings of the company.
In 2028, Stock price target for Nectar Lifesciences Limited (NECLIFE) will be around ₹17.6 on downside and ₹18.5 on upside. Nectar Lifesciences Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for Nectar Lifesciences Limited (NECLIFE) will be around ₹20 Nectar Lifesciences Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of NECLIFE.
The price of Nectar Lifesciences Limited (NECLIFE) shares moved by -0.42%. The short-term trend for NECLIFE share price is Down. It implies that the share price of NECLIFE will stay the same tomorrow and that intraday traders should treat VWAP at 12.05 as a stop loss. Investors with a long-term outlook can track NECLIFE long-term trajectory, which is indicated in the future forecast table.
Estimated DCF Value of NECLIFE stock is Unavailable at this moment. Compared to the current market price of 11.93 INR, the NECLIFE stock is unpredictable by lack of Insufficient data.
As per the fundamental analysis of Nectar Lifesciences Limited (NECLIFE), it is of Uncertain quality in terms of earnings and profit margins with an EPS of 0. Nectar Lifesciences Limited book value per share as of today is 25.51. The current price to book ratio for NECLIFE as of Sep 10, 2026 is 0.47.
NSE:NECLIFE News & Other Useful Information about NECLIFE Share Price
Peer Comparison of NSE: NECLIFE
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Pharmaceuticals
| Company | Price | EPS | BV |
|---|---|---|---|
| SUNPHARMA | 1861.00 | 16.35 | 97.89 |
| DIVISLAB | 9438.50 | 115.55 | 663.06 |
| MEDICAMEQ | 307.50 | 12.15 | 208.08 |
| CIPLA | 1373.30 | 51.67 | 434.03 |
| DRREDDY | 1143.00 | 53.19 | 380.63 |
| TORNTPHARM | 4930.00 | 87.32 | 235.7 |
| BIOCON | 391.65 | 1.27 | 166.51 |
| LUPIN | 2077.80 | 154.86 | 718.37 |
| ALKEM | 5138.00 | 212.33 | 1218.48 |
| AUROPHARMA | 1668.40 | 46.49 | 403.84 |
| ABBOTINDIA | 25260.00 | 766.11 | 2448.41 |
| GLAXO | 2840.90 | 63.65 | 147.25 |
| IPCALAB | 1970.90 | 56.72 | 329.23 |
| LAURUSLABS | 1945.00 | 20.74 | 102.57 |
| LALPATHLAB | 1916.70 | 39.68 | 157.23 |
| PFIZER | 4095.40 | 170.54 | 963.41 |
| AJANTPHARM | 3520.00 | 89.3 | 363.23 |
| SANOFI | 3106.00 | 158.05 | 332.96 |
| NATCOPHARM | 818.65 | 82.14 | 481.67 |
| APLLTD | 816.40 | 48.4 | 295.69 |
| JBCHEPHARM | 2408.90 | 54.16 | 251.48 |
| GLENMARK | 2415.00 | 1.24 | 881.78 |
| AAREYDRUGS | 95.71 | 2.39 | 53.38 |
| JUBLPHARMA | 1025.65 | 4.35 | 145.63 |
| SPARC | 196.91 | 48.14 | 40.45 |
| GRANULES | 896.50 | 23.25 | 180.42 |
| ASTRAZEN | 6860.50 | 86.44 | 364.29 |
| CAPLIPOINT | 2795.40 | 55.52 | 285.6 |
| FDC | 345.35 | 21.19 | 161.21 |
| HIKAL | 234.78 | 9.34 | 96.63 |